ClinicalTrials.gov
public full text
Public Domain
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
head-and-neck-squamous-cell-carcinomamalignant-melanomanon-small-cell-lung-cancertriple-negative-breast-cancer
This is a Phase 1, open-label, first-in-human study of CTX-8371 administered as a monotherapy in patients with metastatic or locally advanced malignancies. The study will be conducted in 2 cohorts: Dose Escalation and Dose Expansion.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors#904169
- Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple Myeloma#892650
- Dose Escalation of IPI-493 in Hematologic Malignancies#895058
- A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour#853718
- Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumors#1112238
Record · ID 804246
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive